Healthcare & Life Sciences
Secure research collaboration, ransomware investigation, pharmaceutical intelligence and device or supplier validation.
The challenge
Healthcare and life sciences organisations run research, clinical trials and security operations alongside systems that hold patient data and support care, and cannot afford to have investigation, testing or research work introduce risk into those systems.
At the same time, research programmes, device development and vendor relationships all generate documentation obligations — for IRBs, FDA submissions or postmarket surveillance — while security teams need to investigate healthcare-specific threats such as ransomware without ever routing that work through clinical infrastructure.
Key solutions
Secure Research Environments
Research and clinical trial teams work in isolated, high-performance environments that protect experimental designs and datasets from unauthorised access or exfiltration. Institutions, CROs and academic partners can collaborate inside the same boundary, with research activity documented to support IRB and regulatory review.
Cybersecurity Operations
Security teams investigate healthcare-specific ransomware and insider-threat activity from an environment kept apart from clinical systems, so the investigation itself cannot become a further point of exposure. The same environments support training on healthcare-specific attack patterns and rehearsal of incident-response playbooks.
Pharmaceutical Intelligence
Competitive and scientific research into drug-development pipelines, clinical trials and patents runs from a workspace that does not reveal the organisation's interest, reaching regulatory databases and restricted literature anonymously. Findings on potential M&A or licensing opportunities are protected within documented, secure environments.
Medical Device Security
Applications, APIs and firmware associated with a medical device are evaluated without connecting to clinical systems or patient data, checking against FDA cybersecurity guidance and ISO 14971 expectations. Findings are documented to support premarket submissions or postmarket surveillance activity.
Healthcare Supply Chain Validation
Software, vendors and digital tools used across the supply chain are tested for interoperability, security and compliance without connecting to real systems, surfacing third-party risk before procurement or integration. The resulting documentation supports risk assessments and vendor-management processes.
Vendor Risk Management
Teams evaluate how healthcare technology partners handle protected health information and test clinical-application integrations in isolated environments before granting access. Verification of FDA and HIPAA-related claims and generated documentation support regulatory audits and vendor certification decisions.
Core capabilities
Secure Research Environments
Proprietary methodologies, clinical research data and experimental findings are protected inside isolated environments designed to prevent leakage or IP theft.
Healthcare Security Operations
Security testing, incident response and threat hunting for healthcare-specific attacks run without exposing clinical systems or patient data.
Comprehensive Audit Capabilities
Detailed, verifiable records of research activity support FDA submissions, clinical trial documentation and regulatory inspections.
Global Collaboration
Distributed research teams and external partners get controlled access to shared work without exposing sensitive data or methodologies.
Working an incident without touching clinical systems
During a suspected ransomware incident, the security team needs to examine attacker infrastructure and malware samples closely enough to understand how the attack unfolded. Doing that analysis from a machine connected to the clinical network would risk extending the incident rather than containing it. Instead, analysts open a disposable workspace with no connection to clinical systems and examine the attacker's infrastructure and captured samples there. Findings and evidence are documented as the investigation proceeds, supporting both the immediate response and any later regulatory notification. Once evidence has been captured, the workspace is retired, leaving nothing from the investigation behind on operational infrastructure.
- 1Open an investigation workspace with no connection to clinical systems
- 2Examine attacker infrastructure and samples, documenting evidence as it emerges
- 3Retire the workspace once evidence capture and response actions are complete
Expected outcomes
- Ransomware and insider-threat investigations proceed without routing through clinical infrastructure
- Research collaboration with external partners is possible without exposing datasets or methodologies
- Device and supplier evaluations are completed before they touch real systems or patient data
- Documentation generated during research and testing supports IRB, FDA and HIPAA-related review
How CyberLane helps
CyberLane helps healthcare and life sciences organisations identify where research, security-investigation and vendor-evaluation workflows currently risk touching clinical systems, and designs the isolated-workspace and documentation approach needed to separate them. We support the business case for adoption, plan a proof of concept against a research or incident-response scenario, and oversee implementation, while platform delivery itself is coordinated with Replica Cyber or a qualified implementation partner.
- Assessment of research, incident-response and vendor-evaluation workflows for clinical-system exposure
- Isolated-environment design for research collaboration and device or supplier testing
- Business case and proof-of-concept plan tailored to a research or security use case
- Documentation approach aligned to IRB, FDA and HIPAA-related expectations
- Implementation oversight coordinated with Replica Cyber or a delivery partner
CyberLane is independent and works on the decision rather than the deployment. Product-specific delivery is coordinated with the vendor or a qualified implementation partner.
Official vendor sources
- Replica Cyber — Healthcare & Life Sciences
- Replica Cyber — Use Cases
- Replica Cyber — Cybercrime Prevention & Analysis
Capability descriptions are based on the vendor's published materials; CyberLane's wording is independently written.
Evaluating Replica Cyber for Healthcare & Life Sciences?
We start with an independent conversation about where your exposure actually sits, before any technology decision is made.